RCAG
BHVN

Rehmann Capital Advisory Group’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Rehmann Capital Advisory Group’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-17
Closed -$638 – 2275
2018
Q3 		$638 Sell
17
-27
-61% -$1.01K ﹤0.01% 2049
2018
Q2 		$1.74K Buy
44
+27
+159% +$1.07K ﹤0.01% 1840
2018
Q1 		$0 Buy
+17
New – ﹤0.01% 2094